Evidence map›Paper›PMID 34928423›Full record

ArticleCancer immunology, immunotherapy : CII2022

Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma.

Johanna Waidhauser, Pia Nerlinger, Tim Tobias Arndt, Stefan Schiele, Florian Sommer, Sebastian Wolf, Phillip Löhr, Stefan Eser, Gernot Müller, Rainer Claus and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Expression of VISTA on T cells in patients with cancer colon.Journal of the Egyptian National Cancer Institute · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Johanna WaidhauserDepartment of Hematology and Oncology, University Medical Center Augsburg, Stenglinstr.2, 86156, Augsburg, Germany. johanna.waidhauser@uk-augsburg.de.ORCID http://orcid.org/0000-0003-2776-1590
Pia NerlingerDepartment of Hematology and Oncology, University Medical Center Augsburg, Stenglinstr.2, 86156, Augsburg, Germany.
Tim Tobias ArndtFaculty of Mathematics and Natural Sciences, Institute of Mathematics, University of Augsburg, Augsburg, Germany.
Stefan SchieleFaculty of Mathematics and Natural Sciences, Institute of Mathematics, University of Augsburg, Augsburg, Germany.
Florian SommerDepartment of General, Visceral and Transplant Surgery, University Medical Center Augsburg, Augsburg, Germany.
Sebastian WolfDepartment of General, Visceral and Transplant Surgery, University Medical Center Augsburg, Augsburg, Germany.
Phillip LöhrDepartment of Hematology and Oncology, University Medical Center Augsburg, Stenglinstr.2, 86156, Augsburg, Germany.
Stefan EserDepartment of Gastroenterology, University Medical Center Augsburg, Augsburg, Germany.
Gernot MüllerFaculty of Mathematics and Natural Sciences, Institute of Mathematics, University of Augsburg, Augsburg, Germany.
Rainer ClausDepartment of Hematology and Oncology, University Medical Center Augsburg, Stenglinstr.2, 86156, Augsburg, Germany.
Bruno MärklGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Andreas RankDepartment of Hematology and Oncology, University Medical Center Augsburg, Stenglinstr.2, 86156, Augsburg, Germany.
University Hospital Augsburg · DEUniversity of Augsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCellular immune response to cancer is known to be of great importance for tumor control. Moreover, solid tumors influence circulating lymphocytes, which has been shown for several types of cancer. In our prospective study we elucidate changes in lymphocyte subsets in patients with colorectal carcinoma compared to healthy volunteers.

methodsFlow cytometry was performed at diagnosis of colon carcinoma to analyze B cells, T cells and NK cells including various subtypes of each group. Univariate and multivariate analyses including age, gender, tumor stage, sidedness and microsatellite instability status (MSI) were performed.

resultsForty-seven patients and 50 healthy volunteers were included. Median age was 65 years in patients and 43 years in the control group. Univariate analysis revealed lower total lymphocyte counts, lower CD4 + cells, CD8 + cells, B cells and NKs including various of their subsets in patients. In multivariate analysis patients had inferior values of B cells, CD4 + cells and NK cells and various subsets, regardless of age and gender. Naïve, central memory and HLADR + CD8 + cells showed an increase in patients whereas all other altered subsets declined. MSI status had no influence on circulating lymphocytes except for higher effector memory CD8 + cells in MSI-high patients. Localization in the left hemicolon led to higher values of total cytotoxic T cells and various T cell subsets.

conclusionWe found significant changes in circulating lymphocyte subsets in colon carcinoma patients, independent of physiological alterations due to gender or age. For some lymphocyte subsets significant differences according to tumor localization or MSI-status could be seen.

Indexed as

CarcinomaColorectal NeoplasmsAgedCD8-Positive T-LymphocytesHumansLymphocyte CountLymphocyte SubsetsMicrosatellite InstabilityProspective StudiesT-Lymphocyte SubsetsCellular immune statusCirculating lymphocytesColorectal carcinomaFlow cytometryTumor immune response

Identifiers

PMID34928423
PMCPMC9293872
OpenAlexW4200051536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.